Next Article in Journal
Inhibition of Galectin-1 and Androgen Receptor Axis Enhances Enzalutamide Treatment in Enzalutamide Resistant Prostate Cancer
Previous Article in Journal
Head and Neck Cancer in Fanconi Anemia: Report of 11 Cases and a Systematic Review
Previous Article in Special Issue
Expression of CD39 Identifies Activated Intratumoral CD8+ T Cells in Mismatch Repair Deficient Endometrial Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349

by
Flavia Fondevila
1,2,
Paula Fernández-Palanca
1,2,
Carolina Méndez-Blanco
1,2,
Tania Payo-Serafín
1,2,
Elisa Lozano
2,3,
Jose J. G. Marin
2,3,
Javier González-Gallego
1,2,† and
José L. Mauriz
1,2,*,†
1
Institute of Biomedicine (IBIOMED), University of León, Campus de Vegazana s/n, 24071 León, Spain
2
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos 5, 28029 Madrid, Spain
3
Experimental Hepatology and Drug Targeting (HEVEPHARM), Salamanca Biomedical Research Institute (IBSAL), University of Salamanca, 37007 Salamanca, Spain
*
Author to whom correspondence should be addressed.
These authors contributed equally to this paper.
Cancers 2025, 17(3), 350; https://doi.org/10.3390/cancers17030350
Submission received: 6 January 2025 / Accepted: 7 January 2025 / Published: 22 January 2025
(This article belongs to the Special Issue Feature Paper from Journal Reviewers)
References Updated
In the original publication [1], Two references from other authors included in this article have been retracted since the publication of our manuscript. These references were not included in the meta-analysis study and originally appeared only in the Introduction and Discussion Sections. The scientific findings and conclusions are not affected. The authors apologize for any inconvenience. The retracted references have been updated in the original publication. This correction was approved by the Academic Editor.
Ref. [17]: Yang, S.; Pang, L.; Dai, W.; Wu, S.; Ren, T.; Duan, Y.; Zheng, Y.; Bi, S.; Zhang, X.; Kong, J. Role of forkhead box O proteins in hepatocellular carcinoma biology and progression (Review). Front. Oncol. 2021, 11, 667730. https://doi.org/10.3389/fonc.2021.667730 instead of Liu, Z.; Li, Z.; Xu, B.; Yao, H.; Qi, S.; Tai, J. Long noncoding RNA PRR34-AS1 aggravates the progression of hepatocellular carcinoma by adsorbing microRNA-498 and thereby upregulating FOXO3. Cancer Manag. Res. 2020, 12, 10749–10762. https://doi.org/10.2147/CMAR.S263619.
Ref. [36]: Yu, S.; Yu, Y.; Zhang, W.; Yuan, W.; Zhao, N.; Li, Q.; Cui, Y.; Wang, Y.; Li, W.; Sun, Y.; et al. FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L. Oncotarget 2016, 7, 34773–34784. https://doi.org/10.18632/oncotarget.8977 instead of Zhou, Y.; Chen, Y.; Ding, W.; Hua, Z.; Wang, L.; Zhu, Y.; Qian, H.; Dai, T. LncRNA UCA1 impacts cell proliferation, invasion, and migration of pancreatic cancer through regulating miR-96/FOXO3. IUBMB Life 2018, 70, 276–290. https://doi.org/10.1002/iub.1699.

Reference

  1. Fondevila, F.; Fernández-Palanca, P.; Méndez-Blanco, C.; Payo-Serafín, T.; Lozano, E.; Marin, J.J.G.; González-Gallego, J.; Mauriz, J.L. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Fondevila, F.; Fernández-Palanca, P.; Méndez-Blanco, C.; Payo-Serafín, T.; Lozano, E.; Marin, J.J.G.; González-Gallego, J.; Mauriz, J.L. Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349. Cancers 2025, 17, 350. https://doi.org/10.3390/cancers17030350

AMA Style

Fondevila F, Fernández-Palanca P, Méndez-Blanco C, Payo-Serafín T, Lozano E, Marin JJG, González-Gallego J, Mauriz JL. Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349. Cancers. 2025; 17(3):350. https://doi.org/10.3390/cancers17030350

Chicago/Turabian Style

Fondevila, Flavia, Paula Fernández-Palanca, Carolina Méndez-Blanco, Tania Payo-Serafín, Elisa Lozano, Jose J. G. Marin, Javier González-Gallego, and José L. Mauriz. 2025. "Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349" Cancers 17, no. 3: 350. https://doi.org/10.3390/cancers17030350

APA Style

Fondevila, F., Fernández-Palanca, P., Méndez-Blanco, C., Payo-Serafín, T., Lozano, E., Marin, J. J. G., González-Gallego, J., & Mauriz, J. L. (2025). Correction: Fondevila et al. Association of FOXO3 Expression with Tumor Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers 2021, 13, 5349. Cancers, 17(3), 350. https://doi.org/10.3390/cancers17030350

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop